speaker
Guillaume Wendt
Evidence Generation Director,
Novartis Pharma GmbH
Get Started Health x Deeptech Network: AI und Pharma
Guillaume has a PhD in Neuroscience and started his career within the Medical Department of Novartis Germany in 2015. He first started leading clinical trials in Neuroscience, then led the early development group. Now Guillaume leads the medical Evidence Generation department which covers all R&D Activities from Phase I to Phase IV in Germany (~ 170 clinical trials and ~100 other data projects) and also ensures the implementation of Advanced Analytics Methods (incl. AI) in local trials and other evidence generation projects.
